Responses

Download PDFPDF
Thromboembolic venous disease
Acute pulmonary embolism revisited
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Comment to Acute pulmonary embolism revisited published in Heart 2008;94:795-802

    To the editor,

    Re: Comment to Acute pulmonary embolism revisited published in Heart 2008;94:795-802.

    We have read with great interest the review article by Dr Konstantinides1 on acute pulmonary embolism (PE) published in the June issue of the journal. Unfortunately this very comprehensive review failed to mention the use of levosimendan in the treatment of right ventricular failure and acute pulmonar...

    Show More
    Conflict of Interest:
    None declared.